ClearPoint Neuro, Inc. (CLPT)
NASDAQ·Healthcare·Medical - Devices
$11.02
-1.69%
Mkt Cap $349.44M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 17, 2026 | $10.05M | $10.40M | +3.48% | -$0.22 | -$0.27 | -22.73% | — | — |
| Q4 2025 Nov 6, 2025 | $10.40M | $8.86M | -14.80% | -$0.20 | -$0.21 | -5.00% | — | — |
| Q3 2025 Aug 12, 2025 | $9.80M | $9.21M | -5.97% | -$0.20 | -$0.21 | -5.00% | — | — |
| Q2 2025 May 13, 2025 | $9.17M | $8.48M | -7.44% | -$0.15 | -$0.22 | -46.67% | — | — |
| Q1 2025 Feb 26, 2025 | $8.23M | $7.77M | -5.57% | -$0.15 | -$0.20 | -33.33% | — | — |
| Q4 2024 Nov 7, 2024 | $7.78M | $8.12M | +4.40% | -$0.17 | -$0.18 | -5.88% | — | — |
| Q3 2024 Aug 7, 2024 | $7.33M | $7.86M | +7.20% | -$0.19 | -$0.16 | +15.79% | — | — |
| Q2 2024 May 7, 2024 | $6.99M | $7.64M | +9.28% | -$0.19 | -$0.16 | +15.79% | — | — |
| Q1 2024 Mar 12, 2024 | $6.53M | $6.81M | +4.29% | -$0.22 | -$0.19 | +13.64% | — | — |
| Q4 2023 Nov 9, 2023 | $6.35M | $5.76M | -9.26% | -$0.25 | -$0.20 | +20.00% | — | — |
| Q3 2023 Aug 8, 2023 | $5.90M | $5.95M | +0.85% | -$0.18 | -$0.29 | -61.11% | — | — |
| Q2 2023 May 11, 2023 | $5.10M | $5.43M | +6.53% | -$0.18 | -$0.23 | -27.78% | — | — |
| Q1 2023 Mar 1, 2023 | $5.20M | $5.17M | -0.50% | -$0.22 | -$0.18 | +18.18% | — | — |
| Q4 2022 Nov 8, 2022 | $5.40M | $5.15M | -4.70% | -$0.19 | -$0.15 | +21.05% | — | — |
| Q3 2022 Aug 9, 2022 | $5.08M | $5.20M | +2.32% | -$0.18 | -$0.18 | +0.00% | — | — |
| Q2 2022 May 11, 2022 | $4.18M | $5.03M | +20.27% | -$0.20 | -$0.17 | +15.00% | — | — |
| Q1 2022 Mar 1, 2022 | $4.30M | $4.28M | -0.42% | -$0.19 | -$0.19 | +0.00% | — | — |
| Q4 2021 Nov 9, 2021 | $4.00M | $4.57M | +14.35% | -$0.16 | -$0.18 | -12.50% | — | — |
| Q3 2021 Aug 10, 2021 | $3.68M | $3.41M | -7.26% | -$0.14 | -$0.17 | -21.43% | — | — |
| Q2 2021 May 11, 2021 | $3.35M | $4.03M | +20.30% | -$0.15 | -$0.13 | +13.33% | — | — |